{"id":"https://openalex.org/W2889562329","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.8556","title":"A comparative safety analysis for durvalumab in patients with locally advanced, unresectable NSCLC: PACIFIC versus pooled durvalumab monotherapy studies.","display_name":"A comparative safety analysis for durvalumab in patients with locally advanced, unresectable NSCLC: PACIFIC versus pooled durvalumab monotherapy studies.","publication_year":2018,"publication_date":"2018-05-20","ids":{"openalex":"https://openalex.org/W2889562329","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.8556","mag":"2889562329"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2018.36.15_suppl.8556","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.8556","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2018.36.15_suppl.8556","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5046273815","display_name":"Scott Joseph Antonia","orcid":"https://orcid.org/0000-0002-6686-3824","observed_orcids":["https://orcid.org/0000-0002-6686-3824"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Scott Joseph Antonia","raw_affiliation_strings":["H. Lee Moffitt Cancer Center &amp; Research Institute, Tampa, FL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H. Lee Moffitt Cancer Center &amp; Research Institute, Tampa, FL;","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029805571","display_name":"Matthew David Hellmann","orcid":"https://orcid.org/0000-0002-2670-9777","observed_orcids":["https://orcid.org/0000-0002-2670-9777"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Matthew David Hellmann","raw_affiliation_strings":["Memorial Sloan Kettering Cancer Center, New York, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan Kettering Cancer Center, New York, NY;","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022984824","display_name":"Phillip A. Dennis","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Phillip A. Dennis","raw_affiliation_strings":["AstraZeneca, Gaithersburg, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca, Gaithersburg, MD;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000029047","display_name":"Giovanni Melillo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Giovanni Melillo","raw_affiliation_strings":["AstraZeneca, Gaithersburg, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca, Gaithersburg, MD;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112689629","display_name":"Shaad Essa Abdullah","orcid":"https://orcid.org/0000-0003-0776-7477","observed_orcids":["https://orcid.org/0000-0003-0776-7477"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shaad Essa Abdullah","raw_affiliation_strings":["MedImmune, Gaithersburg, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MedImmune, Gaithersburg, MD;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031114648","display_name":"Andrew J. Lloyd","orcid":"https://orcid.org/0000-0002-7597-6556","observed_orcids":["https://orcid.org/0000-0002-7597-6556"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Andrew Lloyd","raw_affiliation_strings":["AstraZeneca, Alderley Park, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca, Alderley Park, United Kingdom;","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5075877134","display_name":"Naiyer A. Rizvi","orcid":"https://orcid.org/0000-0002-1134-7494","observed_orcids":["https://orcid.org/0000-0002-1134-7494"]},"institutions":[{"id":"https://openalex.org/I2799503643","display_name":"Columbia University Irving Medical Center","ror":"https://ror.org/01esghr10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799503643"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Naiyer A. Rizvi","raw_affiliation_strings":["Columbia University Medical Center, New York, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Columbia University Medical Center, New York, NY;","institution_ids":["https://openalex.org/I2799503643"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"36","issue":"15_suppl","first_page":"8556","last_page":"8556"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9434000253677368,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9434000253677368,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.030700000002980232,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.019300000742077827,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/durvalumab","display_name":"durvalumab","score":0.9980000257492065},{"id":"https://openalex.org/keywords/pacific-trial","display_name":"PACIFIC trial","score":0.7059999704360962},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.5180000066757202},{"id":"https://openalex.org/keywords/pneumonitis","display_name":"pneumonitis","score":0.9539999961853027},{"id":"https://openalex.org/keywords/radiation-pneumonitis","display_name":"radiation pneumonitis","score":0.9430000185966492},{"id":"https://openalex.org/keywords/treatment-discontinuation","display_name":"treatment discontinuation","score":0.6240000128746033},{"id":"https://openalex.org/keywords/concurrent-chemoradiotherapy","display_name":"concurrent chemoradiotherapy","score":0.800000011920929},{"id":"https://openalex.org/keywords/safety-profile","display_name":"safety profile","score":0.4350000023841858},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.5490000247955322},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.6449999809265137},{"id":"https://openalex.org/keywords/ctcae","display_name":"CTCAE","score":0.4189999997615814}],"concepts":[{"id":"https://openalex.org/C2777742743","wikidata":"https://www.wikidata.org/wiki/Q19904005","display_name":"Durvalumab","level":5,"score":0.9840412735939026},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8652769327163696},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.7053238153457642},{"id":"https://openalex.org/C2779524853","wikidata":"https://www.wikidata.org/wiki/Q1284347","display_name":"Pneumonitis","level":3,"score":0.6172930002212524},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5903090238571167},{"id":"https://openalex.org/C199475168","wikidata":"https://www.wikidata.org/wiki/Q1539689","display_name":"MedDRA","level":4,"score":0.559050977230072},{"id":"https://openalex.org/C3017906399","wikidata":"https://www.wikidata.org/wiki/Q48973845","display_name":"Pooled analysis","level":3,"score":0.5215132832527161},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.3927597999572754},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3321036994457245},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.21186330914497375},{"id":"https://openalex.org/C2777714996","wikidata":"https://www.wikidata.org/wiki/Q7886","display_name":"Lung","level":2,"score":0.11440879106521606},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.10616058111190796},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.10275906324386597},{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.06434068083763123},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.061334848403930664},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C57658597","wikidata":"https://www.wikidata.org/wiki/Q1550789","display_name":"Pharmacovigilance","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2018.36.15_suppl.8556","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.8556","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2018.36.15_suppl.8556","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/14","score":0.7200000286102295,"display_name":"Life below water"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4290785735","https://openalex.org/W4393166246","https://openalex.org/W2791803000","https://openalex.org/W3172131160","https://openalex.org/W2884734693","https://openalex.org/W3014777380","https://openalex.org/W4307584521","https://openalex.org/W3028746215","https://openalex.org/W7112279313","https://openalex.org/W3032664315"],"abstract_inverted_index":{"8556":[0],"Background:":[1],"In":[2,171],"PACIFIC,":[3],"durvalumab":[4,32,57,68,194,237],"significantly":[5],"extended":[6],"PFS":[7],"compared":[8,166],"with":[9,16,52,67,137,167,236,312],"placebo":[10,199],"(HR":[11],"0.52;":[12],"P<0.0001)":[13],"for":[14,64,115,127,207],"pts":[15,65,192,213],"locally":[17],"advanced,":[18],"unresectable":[19],"NSCLC":[20,88,100],"who":[21],"had":[22,143],"previously":[23],"received":[24],"concurrent":[25],"chemoradiotherapy":[26],"(cCRT).":[27],"The":[28,103],"safety":[29,44,227],"profile":[30],"of":[31,46,50,56,105,109,146,156,191,212,234,285,314],"in":[33,188,200,214,231],"this":[34],"study":[35],"was":[36],"similar":[37,203],"to":[38,159,245,304],"placebo.":[39],"Here":[40],"we":[41],"report":[42],"a":[43,47,53,153,172,223],"analysis":[45],"descriptive":[48],"comparison":[49,128,174],"PACIFIC":[51,81,117,130,142,176,201,240,252],"pooled":[54,63,133,139,179,217],"dataset":[55,140,180,256],"monotherapy":[58,69,221,255],"studies.":[59,102],"Methods:":[60],"Data":[61],"were":[62,119],"treated":[66],"(10":[70],"mg/kg":[71],"IV":[72],"Q2W)":[73],"from":[74,177],"three":[75],"trials":[76],"(N=1,889),":[77],"the":[78,116,132,138,178,215,232,239,246],"Phase":[79,83,91],"III":[80],"(n=475),":[82],"II":[84],"ATLANTIC":[85],"(n=444":[86],"advanced":[87],"pts),":[89],"and":[90,124,131,150,195,209,225],"I/II":[92],"1108":[93],"(n=970":[94],"solid":[95],"tumor":[96],"pts,":[97],"including":[98],"304":[99],"pts)":[101],"incidences":[104,145,206],"all-causality":[106],"AEs":[107,149,157,235,286],"(as":[108],"Feb":[110],"13,":[111],"2017,":[112],"data":[113],"cutoff":[114],"analysis)":[118],"graded":[120],"using":[121],"CTCAE":[122],"v4.03":[123],"summarized":[125],"descriptively":[126],"between":[129],"dataset.":[134,218],"Results:":[135],"Compared":[136],"(Table),":[141],"lower":[144],"grade":[147,204,288],"3/4":[148,205,289],"SAEs,":[151],"but":[152],"higher":[154],"rate":[155],"leading":[158,303],"discontinuation":[160],"(15.4%":[161],"[durvalumab]":[162],"vs.":[163],"9.8%":[164],"[placebo]":[165],"9.4%":[168],"[pooled":[169],"dataset]).":[170],"separate":[173],"excluding":[175],"(N=1,414),":[181],"any-grade":[182],"(grade":[183],"3/4)":[184],"pneumonitis/radiation":[185],"pneumonitis":[186],"occurred":[187],"33.9%":[189],"(3.4%)":[190],"on":[193,198,238],"24.8%":[196],"(3.0%)":[197],"(with":[202],"both)":[208],"2.3%":[210],"(0.5%)":[211],"reduced":[216],"Conclusions:":[219],"Durvalumab":[220,258],"has":[222],"well-defined":[224],"acceptable":[226],"profile.":[228],"Differences":[229],"observed":[230],"rates":[233],"regimen":[241],"may":[242],"be":[243],"attributable":[244],"pt":[247],"population":[248],"or":[249],"prior":[250],"cCRT.":[251],"Demographics":[253],"Pooled":[254],"(N=1,889)":[257],"(n=475)":[259],"Placebo":[260],"(n=234)":[261],"Median":[262],"age":[263],"(range),":[264],"years":[265],"63.0":[266],"(19\u201396)":[267],"64.0":[268],"(31\u201384)":[269],"63.5":[270],"(23\u201390)":[271],"Age":[272],"\u226575":[273],"years,":[274],"%":[275,280,306,316,322,328],"10.0":[276],"7.6":[277],"7.7":[278],"Male,":[279],"59.8":[281],"70.1":[282],"69.7":[283],"Overview":[284],"Exposure-adjusted":[287,295],"AEs,*":[290],"n":[291,297],"94.0":[292],"47.5":[293],"46.8":[294],"SAEs,*":[296],"79.5":[298],"42.5":[299],"38.2":[300],"Any":[301,310,320,326],"AE":[302,311],"discontinuation,":[305],"9.4":[307],"15.4":[308],"9.8":[309],"outcome":[313],"death,":[315],"5.4":[317],"4.4":[318],"6.0":[319],"AESI,":[321],"55.5":[323],"65.5":[324],"48.7":[325],"imAE,":[327],"15.6":[329],"24.2":[330],"8.1":[331],"*Reported":[332],"as":[333],"events":[334],"per":[335],"100":[336],"pt-years":[337]},"counts_by_year":[{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1}],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2018-09-27T00:00:00"}